FILTER

Refine your search with the following facets to narrow down your results.

4 Current news of Sanochemia Pharmazeutika

Changes on the Board of Management and Supervisory Board of Sanochemia Pharmazeutika AG

12-Aug-2009 - Sanochemia Pharmazeutika AG announced changes in terms of the management of Sanochemia Pharmazeutika AG for urgent medical reasons pertaining to the former CEO/CFO Herbert Frantsits. With immediate effect, Werner Frantsits, founder, former CEO and long-standing Chairman of the Supervisory ...

Avigen Licenses Unique Neuroactive Compound for Disabling Neuromuscular Conditions from Sanochemia

18-Jan-2006 - Avigen, Inc. announced it has signed an agreement with SDI Diagnostics International LTD ("SDI"), a division of Sanochemia Pharmazeutika AG. Under the terms of the agreement, Avigen receives an exclusive North American license to develop and commercialize proprietary formulations of the ...

active pharmaceutical ingredients neurological diseases neuropathic pain

Sanochemia acquires rights to phase II compound PVP Hypericin for innovative cancer diagnostic and treatments

11-Jul-2005 - Sanochemia Pharmazeutika AG, Vienna has acquired exclusive global rights from Planta Naturstoffe GmbH, Vienna, to a novel API known as PVP hypericin for use in the diagnosis and treatment of tumours. Hypericin is a well known plant-based API. The complex compound polyvinylpyrrolidon (PVP) ...

fluorescent dyes

Sanochemia Establishes New Focus in Peripheral Nervous System Therapy

14-Feb-2005 - Sanochemia Pharmazeutika AG has concluded a licensing agreement with Polymun Scientific Immunobiologische Forschung GmbH. The agreement gives Sanochemia access to an innovative formulation technology which - among other applications - could provide new avenues to the treatment of neuropathic ...

clinical trials neuropathic pain pain